Total Payments
$3,334
2024 Payments
$502.67
Companies
32
Transactions
96
Medicare Patients
2,691
Medicare Billing
$660,926
Payment Breakdown by Category
Food & Beverage$3,301 (99.0%)
Education$32.27 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,301 | 95 | 99.0% |
| Education | $32.27 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $661.49 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $549.11 | 12 | $0 (2024) |
| Horizon Therapeutics plc | $222.63 | 11 | $0 (2023) |
| NxStage Medical, Inc. | $220.36 | 4 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $205.39 | 5 | $0 (2023) |
| Novo Nordisk Inc | $192.33 | 4 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $122.20 | 1 | $0 (2017) |
| Ardelyx, Inc. | $119.59 | 1 | $0 (2024) |
| Baxter Healthcare | $115.00 | 1 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $109.19 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $502.67 | 9 | Novo Nordisk Inc ($179.62) |
| 2023 | $1,086 | 22 | Amgen Inc. ($500.39) |
| 2022 | $660.26 | 23 | Takeda Pharmaceuticals U.S.A., Inc. ($153.29) |
| 2021 | $392.39 | 15 | NxStage Medical, Inc. ($102.81) |
| 2020 | $159.48 | 8 | Relypsa, Inc. ($57.17) |
| 2019 | $58.54 | 2 | AstraZeneca Pharmaceuticals LP ($47.50) |
| 2018 | $73.87 | 4 | Fresenius USA Marketing, Inc. ($37.33) |
| 2017 | $400.52 | 13 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $119.59 | General |
| Category: NEPHROLOGY | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Inflammation | ||||||
| 04/28/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: Hyperkalemia | ||||||
| 02/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $114.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $30.10 | General |
| Category: Nephrology | ||||||
| 09/05/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: KRYSTEXXA | ||||||
| 07/17/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/12/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 06/29/2023 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $127.08 | General |
| Category: Nephrology | ||||||
| 06/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Cardio-renal | ||||||
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $123.60 | General |
| Category: Inflammation | ||||||
| 05/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DIABETES | ||||||
| 05/06/2023 | Amgen Inc. | Parsabiv (Drug), TAVNEOS | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: Nephrology | ||||||
| 04/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $28.14 | General |
| 04/10/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 541 | 1,148 | $384,857 | $120,259 |
| 2022 | 8 | 678 | 1,458 | $519,741 | $155,255 |
| 2021 | 8 | 695 | 1,577 | $622,200 | $188,579 |
| 2020 | 8 | 777 | 1,710 | $825,723 | $196,833 |
Total Patients
2,691
Total Services
5,893
Medicare Billing
$660,926
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 97 | 424 | $109,477 | $39,641 | 36.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 105 | 105 | $95,167 | $28,543 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 111 | 162 | $74,193 | $22,129 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 235 | $77,080 | $21,346 | 27.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 14 | 14 | $10,503 | $3,219 | 30.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 22 | $7,484 | $2,223 | 29.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 31 | $7,167 | $1,965 | 27.4% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 18 | 155 | $3,787 | $1,193 | 31.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 150 | 657 | $169,637 | $53,927 | 31.8% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 135 | 144 | $130,514 | $40,682 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 150 | 250 | $114,495 | $29,298 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 175 | $57,400 | $16,149 | 28.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 24 | 24 | $18,005 | $5,811 | 32.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 33 | 33 | $16,524 | $5,314 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 43 | $9,941 | $3,024 | 30.4% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 14 | 132 | $3,225 | $1,051 | 32.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 148 | 706 | $201,332 | $59,589 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 469 | $161,464 | $47,517 | 29.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 115 | 133 | $120,948 | $39,910 | 33.0% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 98 | 101 | $77,694 | $22,737 | 29.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 47 | $21,525 | $7,196 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 85 | $20,345 | $6,367 | 31.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $9,464 | $2,858 | 30.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $9,429 | $2,405 | 25.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 265 | 311 | $291,535 | $68,701 | 23.6% |
About Dr. David Ono, M.D
Dr. David Ono, M.D is a Nephrology healthcare provider based in Honolulu, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073557096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ono, M.D has received a total of $3,334 in payments from pharmaceutical and medical device companies, with $502.67 received in 2024. These payments were reported across 96 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,301).
As a Medicare-enrolled provider, Ono has provided services to 2,691 Medicare beneficiaries, totaling 5,893 services with total Medicare billing of $660,926. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Honolulu, HI
- Active Since 06/16/2006
- Last Updated 10/10/2007
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1073557096
Products in Payments
- Parsabiv (Drug) $458.94
- LOKELMA (Drug) $306.59
- KRYSTEXXA (Biological) $255.37
- FARXIGA (Drug) $242.52
- Ozempic (Drug) $192.33
- TAVNEOS (Drug) $142.99
- Veltassa (Drug) $140.44
- NXSTAGE SYSTEM ONE (Device) $124.91
- TOLVAPTAN (Drug) $122.20
- XPHOZAH 30 MG (Drug) $119.59
- Renal - PD (Device) $115.00
- LIVTENCITY (Drug) $114.80
- System One (Device) $95.45
- Velphoro (Drug) $91.22
- GATTEX (Drug) $90.59
- JYNARQUE (Drug) $77.10
- TARPEYO (Drug) $67.64
- PURIFIED CORTROPHIN GEL (Drug) $65.88
- Kerendia (Drug) $44.53
- Rituxan (Biological) $40.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Honolulu
Dr. Kunal Parekh, M.d, M.D
Nephrology — Payments: $120,528
Nephrology $120,528
Jared Sugihara, M.d, M.D
Nephrology — Payments: $94,214
Nephrology $94,214
Dr. Eugene Wong, Md, MD
Nephrology — Payments: $41,456
Nephrology $41,456
Dr. Christie Izutsu, M.d, M.D
Nephrology — Payments: $23,982
Nephrology $23,982
Shiuh-Feng Cheng, M.d, M.D
Nephrology — Payments: $16,654
Nephrology $16,654
Leilani Ka'anehe, Md, MD
Nephrology — Payments: $10,704
Nephrology $10,704